ClearPoint Neuro (CLPT) Competitors $15.55 +0.89 (+6.07%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLPT vs. RXST, INMD, MDXG, ESTA, BLFS, PLSE, AORT, EMBC, CBLL, and LQDAShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia RxSight (NASDAQ:RXST) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk, community ranking and earnings. Which has more risk & volatility, RXST or CLPT? RxSight has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Does the media favor RXST or CLPT? In the previous week, RxSight had 11 more articles in the media than ClearPoint Neuro. MarketBeat recorded 11 mentions for RxSight and 0 mentions for ClearPoint Neuro. RxSight's average media sentiment score of 0.05 beat ClearPoint Neuro's score of 0.00 indicating that RxSight is being referred to more favorably in the media. Company Overall Sentiment RxSight Neutral ClearPoint Neuro Neutral Is RXST or CLPT more profitable? RxSight has a net margin of -23.92% compared to ClearPoint Neuro's net margin of -59.64%. RxSight's return on equity of -14.00% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets RxSight-23.92% -14.00% -12.51% ClearPoint Neuro -59.64%-62.10%-38.39% Do institutionals & insiders have more ownership in RXST or CLPT? 78.8% of RxSight shares are held by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are held by institutional investors. 9.4% of RxSight shares are held by insiders. Comparatively, 6.1% of ClearPoint Neuro shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has stronger earnings & valuation, RXST or CLPT? ClearPoint Neuro has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$128.29M10.57-$48.61M-$0.83-40.55ClearPoint Neuro$30.43M14.10-$22.09M-$0.69-22.54 Do analysts rate RXST or CLPT? RxSight presently has a consensus target price of $59.00, indicating a potential upside of 75.28%. ClearPoint Neuro has a consensus target price of $11.33, indicating a potential downside of 27.12%. Given RxSight's higher possible upside, equities research analysts clearly believe RxSight is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer RXST or CLPT? RxSight received 24 more outperform votes than ClearPoint Neuro when rated by MarketBeat users. However, 88.00% of users gave ClearPoint Neuro an outperform vote while only 69.70% of users gave RxSight an outperform vote. CompanyUnderperformOutperformRxSightOutperform Votes4669.70% Underperform Votes2030.30% ClearPoint NeuroOutperform Votes2288.00% Underperform Votes312.00% SummaryRxSight beats ClearPoint Neuro on 12 of the 18 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$428.81M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-22.5425.3790.0517.18Price / Sales14.1045.921,117.14116.99Price / CashN/A43.4443.0437.86Price / Book18.087.094.784.78Net Income-$22.09M$13.64M$120.31M$225.60M7 Day Performance1.47%-2.93%-1.92%-1.23%1 Month Performance40.22%0.28%11.51%3.36%1 Year Performance134.89%40.76%30.61%16.60% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro0.45 of 5 stars$15.55+6.1%$11.33-27.1%+142.2%$428.81M$30.43M-22.54110RXSTRxSight2.9521 of 5 stars$38.79+4.0%$62.13+60.2%-11.8%$1.56B$89.08M-46.59220Analyst DowngradeINMDInMode3.6341 of 5 stars$18.15-0.6%$22.60+24.5%-21.7%$1.52B$423.75M9.87480Positive NewsMDXGMiMedx Group2.8123 of 5 stars$9.50+3.7%$12.00+26.3%+1.7%$1.40B$342.80M16.65895ESTAEstablishment Labs2.5211 of 5 stars$46.74+1.6%$60.60+29.7%+73.3%$1.31B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2602 of 5 stars$27.37+2.5%$28.29+3.3%+79.4%$1.27B$146.96M-25.19409Analyst ForecastInsider TradeNews CoveragePLSEPulse Biosciences1.8256 of 5 stars$20.33+15.2%N/A+56.3%$1.25B$700,000.000.00140Insider TradeNews CoverageAORTArtivion2.2159 of 5 stars$29.21+1.0%$31.80+8.9%+59.5%$1.22B$384.90M-1,446.501,500EMBCEmbecta3.7712 of 5 stars$19.86+1.8%$23.00+15.8%+13.5%$1.15B$1.12B14.712,200Short Interest ↓CBLLCeriBellN/A$29.210.0%$32.60+11.6%N/A$1.05B$60.04M0.00N/ALQDALiquidia3.4225 of 5 stars$11.00+0.7%$24.00+118.2%+3.7%$931.01M$15.61M-6.7050Analyst ForecastNews CoveragePositive News Related Companies and Tools Related Companies RxSight Competitors InMode Competitors MiMedx Group Competitors Establishment Labs Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Artivion Competitors Embecta Competitors CeriBell Competitors Liquidia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLPT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLPT Stock Alerts